A specific VEGF-R tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in ErbB-2 overexpressing breast cancer cells

被引：0
|
作者：
Kim, E. [1 ]
Lobocki, C. A. [1 ]
Dubay, L. [1 ]
Mittal, V. [1 ]
机构：
[1] Providence Hosp, Med Ctr, Southfield, MI 48037 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2007年 / 14卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [41] Association of Csk-homologous kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in breast cancer cells
    ZrihanLicht, S
    Lim, J
    Keydar, I
    Sliwkowski, MX
    Groopman, JE
    Avraham, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) : 1856 - 1863
  • [42] Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel
    Zhang, LS
    Lau, YK
    Xia, WY
    Hortobagyi, GN
    Hung, MC
    CLINICAL CANCER RESEARCH, 1999, 5 (02) : 343 - 353
  • [43] Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
    Konecny, GE
    Pegram, MD
    Venkatesan, N
    Finn, R
    Yang, GR
    Rahmeh, M
    Untch, M
    Rusnak, DW
    Spehar, G
    Mullin, RJ
    Keith, BR
    Gilmer, TM
    Berger, M
    Podratz, KC
    Slamon, DJ
    CANCER RESEARCH, 2006, 66 (03) : 1630 - 1639
  • [44] Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
    Canfield, Kaleigh
    Li, Jiaqi
    Wilkins, Owen M.
    Morrison, Meghan M.
    Ung, Matthew
    Wells, Wendy
    Williams, Charlotte R.
    Liby, Karen T.
    Vullhorst, Detlef
    Buonanno, Andres
    Hu, Huizhong
    Schiff, Rachel
    Cook, Rebecca S.
    Kurokawa, Manabu
    CELL CYCLE, 2015, 14 (04) : 648 - 655
  • [45] SUCI02 inhibits the erbB-2 tyrosine kinase receptor signaling pathway and arrests the cell cycle in G1 phase in breast cancer cells
    Zhu, XF
    Wang, JS
    Cai, LL
    Zeng, YX
    Yang, D
    CANCER SCIENCE, 2006, 97 (01) : 84 - 89
  • [46] IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer
    Bruchim, Ilan
    Sarfstein, Rive
    Reiss, Ari
    Flescher, Eliezer
    Werner, Haim
    CANCER LETTERS, 2014, 352 (02) : 214 - 219
  • [47] Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2
    Cuello, M
    Ettenberg, SA
    Clark, AS
    Keane, MM
    Posner, RH
    Nau, MM
    Dennis, PA
    Lipkowitz, S
    CANCER RESEARCH, 2001, 61 (12) : 4892 - 4900
  • [48] Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells
    Delacroix, L
    Begon, D
    Chatel, G
    Jackers, P
    Winkler, R
    DNA AND CELL BIOLOGY, 2005, 24 (09) : 582 - 594
  • [49] X-Linked Inhibitor of Apoptosis Protein Inhibits Apoptosis in Inflammatory Breast Cancer Cells with Acquired Resistance to an ErbB1/2 Tyrosine Kinase Inhibitor
    Aird, Katherine M.
    Ghanayem, Rami B.
    Peplinski, Sharon
    Lyerly, Herbert K.
    Devi, Gayathri R.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1432 - 1442
  • [50] ALTERNATIVE RECEPTOR TYROSINE KINASE SIGNALLING IN TRASTUZUMAB RESISTANT HER-2 POSITIVE BREAST CANCER CELLS
    Browne, B.
    Crown, J.
    Clynes, M.
    Duffy, M. J.
    Slamon, D.
    O'Donovan, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 47 - 48
12345